LIF transduces contradictory signals on capillary outgrowth through induction of Stat3 and (P41/433)MAP kinase

Journal of Cell Science

Volumn 113, Issue 23, 2000, Pages 4331-4339

  Paradis, H ^a   Gendron, R L ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

(P41 43MAPK; Angiogenesis; Embryonic; Endothelial cell; In vitro; LIF; Stat3

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; JANUS KINASE; LEUKEMIA INHIBITORY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; PROTEIN TYROSINE KINASE; STAT3 PROTEIN; SUPPRESSOR FACTOR; TRANSCRIPTION FACTOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CAPILLARY; CELL STIMULATION; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITION; IN VITRO STUDY; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

CAPILLARIES; CARRIER PROTEINS; CELLS, CULTURED; DNA-BINDING PROTEINS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; ENZYME INHIBITORS; FETUS; FLAVONOIDS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GROWTH INHIBITORS; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; MITOGEN-ACTIVATED PROTEIN KINASE 1; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEINS; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0034531521     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (78)

1. Roles of ephrinB ligands and EphB receptors in cardiovascular development: Demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis
2. Embryonic vasculogenesis by endothelial precursor cells derived from lung mesenchyme
3. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
4. Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter
5. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway
6. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor
7. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6
8. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
9. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
10. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3
11. Interleukin 6 induces the expression of vascular endothelial growth factor
12. Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin
13. A synthetic inhibitor of the mitogen-activated protein kinase cascade
14. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo
15. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3
16. STAT signaling is active during early mammalian development
17. Role of suppressors of cytokine signaling (Socs) in leukemia inhibitory factor (LIF)-dependent embryonic stem cell survival
18. A new protein containing an SH2 domain that inhibits JAK kinases
19. Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: Identification as leukemia inhibitory factor
20. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
21. Molecular mechanisms of vasculogenesis and embryonic angiogenesis
22. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
23. The regulation of endothelial cell motility by p21 ras
24. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis
25. 1 to S cell-cycle transition
26. Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle-sized T antigen: Implications for the pathogenesis of opportunistic vascular tumors
27. Induction of embryonic vasculogenesis by bFGF and LIF in vitro and in vivo
28. She mediates IL-6 signaling by interacting with gp130 and Jak2 kinase
29. IL-6 is an in vitro and in vivo autocrine growth factor for middle T antigen-transformed endothelial cells
30. Signaling vascular morphogenesis and maintenance
31. Isolation and characterization of endothelial progenitor cells from mouse embryos
32. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
33. Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein
34. Eph receptors and ephrins: Effectors of morphogenesis
35. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain
36. Dual control of neurite outgrowth by STAT3 and MAP kinase in PC12 cells stimulated with interleukin-6
37. Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis
38. Regulation of cell motility by mitogen-activated protein kinase
39. Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells
40. Endothelial receptor tyrosine kinases activate the STAT signaling pathway: Mutant Tie-2 causing venous malformations signals a distinct STAT activation response
41. The role of matrix metalloproteinase activity in the maturation of human capillary endothelial cells in vitro
42. SOCS: Physiological suppressors of cytokine signaling
43. Adenoviral-mediated expression of antisense RNA to fibroblast growth factors disrupts murine vascular development
44. In vitro endothelial differentiation of long-term cultured murine embryonic yolk sac cells induced by matrigel
45. Stat5a is mandatory for adult mammary gland development and lactogenesis
46. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
47. Virally activated Ras cooperates with integrin to induce tubulogenesis in sinusoidal endothelial cell lines
48. Cloning and characterization of novel CIS family genes
49. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line
50. Structure and function of a new STAT-induced STAT inhibitor
51. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice
52. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells
53. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction
54. Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes
55. Differentiation responses of embryonic endothelium to leukemia inhibitory factor
56. Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro
57. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors
58. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
59. Box 3-independent signaling mechanisms are involved in leukemia inhibitory factor receptor alpha-and gp130-mediated stimulation of mitogen-activated protein kinase. Evidence for participation of multiple converge at Ras
60. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
61. Activation of Stat3 is involved in the induction of apoptosis after ligation of major histocompatibility complex class I molecules on human Jurkat T cells
62. Interference with endogenous ras function inhibits cellular responses to wounding
63. Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway
64. A family of cytokine-inducible inhibitors of signalling
65. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
66. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality
67. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: Generation and characterization of T cell-specific Stat3-deficient mice
68. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression
69. Isolation and propagation of yolk-sac-derived endothelial cells from a hypervascular transgenic mouse expressing a gain-of-function fps/fes proto-oncogene
70. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death
71. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukine-6 at the posttranslational level
72. Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene
73. Endothelial apoptosis in Braf-deficient mice
74. Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation
75. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders
76. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation
77. Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6